HPL results Hoechst Pakistan Limited
Hoechst Pakistan Limited (HPL) has 9 results with figures on file. Quarter ended 30 Sep 2026: earnings per share Rs 63.70, sales Rs 7.8 bn, down 29.8% on the same quarter a year before. The next results are expected between 15 Feb 2027 and 25 Feb 2027 (a projection, not an announced date).
One line for each result
- Quarter ended 30 Sep 2026: earnings per share Rs 63.70, sales Rs 7.8 bn, down 29.8% on the same quarter a year before.
- Quarter ended 30 Jun 2026: earnings per share Rs 152.94, sales Rs 9.0 bn, up 86.6% on the same quarter a year before.
- Quarter ended 31 Mar 2026: earnings per share Rs 74.71, sales Rs 7.7 bn.
- Year ended 31 Dec 2025: earnings per share Rs 301.67, sales Rs 30.9 bn, up 56.7% on the year before.
- Quarter ended 30 Sep 2025: earnings per share Rs 90.79, sales Rs 8.3 bn.
- Quarter ended 30 Jun 2025: earnings per share Rs 81.94, sales Rs 8.7 bn.
- Year ended 31 Dec 2024: earnings per share Rs 192.56, sales Rs 26.7 bn, up 414.7% on the year before.
- Year ended 31 Dec 2023: earnings per share Rs 37.41, sales Rs 21.4 bn, up 116.4% on the year before.
- Year ended 31 Dec 2022: earnings per share Rs 17.29, sales Rs 18.6 bn.
Written from the figures below. Company accounts as filed. Earnings per share are on today’s share count where a split or bonus issue came later.
When the next results are due
Next results
Full-year results, to 31 Dec 2026: expected between 15 Feb 2027 and 25 Feb 2027.
A projection, not an announced date. An estimate from the dates of the last 3 filings.
Results dates on record
| Date | What | Status |
|---|---|---|
| 15 Feb 2027 | Full-year results expected between 15 Feb 2027 and 25 Feb 2027 | Expected window, not an announced date |
| 21 Oct 2026 | Nine-month results, to 30 Sep 2026 | Filed with the exchange |
Source: the exchange’s results announcements. An expected window is an estimate from the dates of earlier filings.
Results by quarter
5 of the last 8 quarters. The fourth quarter is filed only inside the annual accounts.
| Quarter | Earnings per share (Rs) | Sales | Profit after tax | Net profit as a share of sales | Change on the same quarter a year before |
|---|---|---|---|---|---|
| Quarter to 30 Sep 2026 | 63.70 | Rs 7.8 bn | Rs 614.3 m | 7.9% | -29.8% |
| Quarter to 30 Jun 2026 | 152.94 | Rs 9.0 bn | Rs 1.5 bn | 16.4% | +86.6% |
| Quarter to 31 Mar 2026 | 74.71 | Rs 7.7 bn | Rs 720.6 m | 9.4% | — |
| Quarter to 30 Sep 2025 | 90.79 | Rs 8.3 bn | Rs 875.7 m | 10.6% | — |
| Quarter to 30 Jun 2025 | 81.94 | Rs 8.7 bn | Rs 790.3 m | 9.1% | — |
Results filings at the exchange
| Date | Filing | Kind | |
|---|---|---|---|
| 30 Oct 2026 | TRANSMISSION OF QUARTERLY REPORT FOR THE PERIOD ENDED SEPTEMBER 30, 2026 | Quarterly accounts | |
| 21 Oct 2026 | FINANCIAL RESULTS FOR THE NINE MONTHS AND QUARTER ENDED SEPTEMBER 30, 2026 | Quarterly accounts | |
| 28 Aug 2026 | Quarterly report 2026 | Quarterly accounts | |
| 20 Aug 2026 | FINANCIAL RESULTS FOR THE HALF YEAR ENDED JUNE 30, 2026 | Half-yearly accounts | |
| 22 Apr 2026 | FINANCIAL RESULTS FOR THE QUARTER ENDED MARCH 31, 2026 | Quarterly accounts | |
| 31 Mar 2026 | Quarterly report 2026 | Quarterly accounts | |
| 30 Sep 2025 | Quarterly report 2025 | Quarterly accounts | |
| 30 Jun 2025 | Quarterly report 2025 | Quarterly accounts | |
| 31 Mar 2025 | Quarterly report 2025 | Quarterly accounts | |
| 30 Sep 2024 | Quarterly report 2024 | Quarterly accounts | |
| 30 Jun 2024 | Quarterly report 2024 | Quarterly accounts | |
| 31 Mar 2024 | Quarterly report 2024 | Quarterly accounts | |
| 30 Sep 2023 | Quarterly report 2023 | Quarterly accounts |
13 filings stored.
More on HPL
- HPL share price and overview
- HPL dividend history
- Pharmaceuticals sector
- IBLHL results · IBL HealthCare Limited
- LIVEN results · Liven Pharma Limited
- MACTER results · Macter International Limited
- GLAXO results · GlaxoSmithKline Pakistan Limited
- ABOT results · Abbott Laboratories (Pakistan) Limited
- HALEON results · Haleon Pakistan Limited
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .